Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: Association with renal involvement

Pediatric Allergy and Immunology

Volumn 22, Issue 1 PART 1, 2011, Pages 54-59

  Qin, Wang ^a   Hongya, Wu ^b   Yongjing, Chen ^a   Fang, Xie ^a   Yue, Min ^c   Xuekun, Zhang ^a   Xiaozhong, Li ^c   Xueguang, Zhang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Clinical Immunology Research Laboratory of Jiangsu Province   (China)

^c CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

CD4+ T cell; Henoch Schonlein purpura; Nephritis; OX40; SOX40L

Indexed keywords

CD134 ANTIGEN; OX40 LIGAND;

ANAPHYLACTOID PURPURA; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MALE; NEPHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SURVIVAL; T LYMPHOCYTE ACTIVATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; FEMALE; HUMANS; MALE; NEPHRITIS; OX40 LIGAND; PURPURA, SCHOENLEIN-HENOCH; RECEPTORS, OX40; SIGNAL TRANSDUCTION; SOLUBILITY; UP-REGULATION;

EID: 78851472286     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01111.x     Document Type: Article

References (30)

1. Cassidy JT, Petty RE. Vasculitis, Henoch-Schonlein purpura. In: Cassidy JT, Petty E, eds. Pediatric Rheumatolog, 3rd edn. Philadelphia: Saunders, 1995: 384-8.
2. Bagga ADM. Leukocytoclastic vasculitis. In: Petty RE, Cassidy JT, ed. Textbook of Pediatric Rheumatology. Philadelphia: WB. Saunders Co, 2001: 569-74.
3. Haycock GB. The nephritis of Henoch-Schonlein purpura. In: Davidson AM, Cameron JS, Gronfeld JP, Kerr D, Ritz E, eds. Oxford Textbook of Clinical Nephrology, 2nd edn. New York: Oxford Medical Publications, 1998: 845-917.
4. Leung DY. Immunologic aspects of Kawasaki syndrome. J Rheumatol Suppl 1990: 24: 15-8.
5. Mckee PH, Calonje E, Granter SR. Vascular diseases, leukocytoclastic vasculitis. In: McKee PH, Calonje E, Granter SR, eds. Pathology of the Skin, 3rd edn. Philadelphia: Mosby, 2005: 709-75.
6. Paterson DJ, Jefferies WA, Green JR, et al. Antigens of activated rat T lymphocytes including a molecule of 50, 000 Mr detected only on CD4 positive T blasts. Mol Immunol 1987: 24: 1281-90.
7. Ohshima Y, Tanaka Y, Tozawa H, et al. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997: 159: 3838-48.
8. Pippig SD, Pena-Rossi C, Long J, et al. Robust B-cell immunity but impaired T-cell proliferation in the absence of CD134 (OX40). J Immunol 1999: 163: 6520-9.
9. Imura A, Hori T, Imada K, et al. The human OX40/gp34 system directly mediates adhesion of activated T-cells to vascular endothelial cells. J Exp Med 1996: 183: 2185-95.
10. Wang Q, Chen Y, Xie F, et al. Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease. Cytokine 2006: 36: 23-8.
11. Gough MJ, Weinberg AD. OX40 (CD134) and OX40L. Adv Exp Med Biol 2009: 647: 94-107.
12. Matsumura Y, Imura A, Hori T, et al. Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T-cells and endothelial cells in infiltration. Arch Dermatol Res 1997: 289: 653-6.
13. Ndhlovu LC, Ishii N, Murata K, et al. Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 2001: 167: 2991-9.
14. Yoshioka T, Nakajima A, Akiba H, et al. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol 2000: 30: 2815-23.
15. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999: 45: 856-63.
16. Kotani A, Ishikawa T, Matsumura Y, et al. Correlation of peripheral blood OX40+ (CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation. Blood 2001: 98: 3162-4.
17. Nohar C, Akiba H, Nakajima A, et al. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J Immunol 2001: 166: 2108-15.
18. Martin-Orozco N, Chen Z, Poirot L, et al. Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand. J Immunol 2003: 171: 6954-60.
19. Blazar BR, Sharpe AH, Chen AI, et al. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blood 2003: 101: 3741-8.
20. Ozen S, Pistorio A, Lusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 2010: 69: 798-806.
21. Giacomelli R, Passacantando A, Perricone Parzanese I, et al. T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen. Clin Exp Rheumatol 2001: 19: 317-20.
22. + T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 2006: 145: 235-42.
23. Zhao XY, Pirskanen R, Malmstorm V, Lefvert AK. Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis. Clin Exp Immunol 2005: 143: 110-6.
24. Wilde B, Dolff S, Cai X, et al. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's glanulomatosis. Nephrol Dial Transplant 2009: 24: 161-71.
25. Yan JC, Chen GH, Gong J, et al. Upregulation of OX40-OX40L system on T lymphocytes in patients with acute coronary syndromes. J Cardiovasc Pharmacol 2009: 54: 451-5.
26. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann N Y Acad Sci 2007: 1107: 22-31.
27. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006: 26: 2421-32.
28. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003: 349: 160-9.
29. Yang HY, Chuang HY, Wang LC, et al. The immunobiology of Henoch-Schonlein purpura. Autoimmun Rev 2008: 7: 179-84.
30. Wiercinski R, Zoch-Zwierz W, Wasilewska A, et al. Lymphocyte subpopulations of peripheral blood in children with Schonlein-Henoch purpura and IgA nephropathy. Pol Merkur Lekarski 2001: 10: 244-6.